Anti-diabetes drug

Drugs used in diabetes to treat diabetes mellitus by altering the glucose level in the blood. With the exceptions of insulin, exenatide, liraglutide and pramlintide, all are administered orally and are thus also known oral hypoglycemia agents or oral anti-hyperglycemia agents. There are different classes of anti-diabetic drugs, and their selection depends upon the nature of the diabetes, age and situation of the person, as well as other factors. Diabetes mellitus type 1 is a disease caused by the shortage of insulin. Insulin must be used in type1, which must be injected. Diabetes mellitus type 2 is a disease of insulin resistance by the cells.

  • Types and causes
  • Complications
  • Diagnosis & Treatment

Related Conference of Anti-diabetes drug

February 24-25, 2025

34th European Diabetes Congress

London, UK
March 10-11, 2025

4th Global Summit on Physiology and Metabolism of Thyroid

Singapore City, Singapore
March 17-18, 2025

5th European Endocrinology and Diabetes Congress

Paris, France
April 10-11, 2025

5th World Congress on Endocrine and Diabetes

Dubai, UAE
April 10-11, 2025

4th International Summit on Hormonal Disorders

Dubai, UAE
May 19-20, 2025

6th World Summit on Diabetes

Rome, Italy
June 04-05, 2025

4th World Congress on Diabetes and Pediatric Endocrinology

Edinburgh, Scotland
July 29-30, 2025

15th World Congress on Endocrinology and Diabetes

Aix-en-Provence, France
September 08-09, 2025

3rd World congress and Expo on Diabetes

Frankfurt, Germany
November 20-21, 2025

21st World Congress on Endocrinology & Diabetes

Aix-en-Provence, France

Anti-diabetes drug Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in